Stockscreener 앱 받기
30.06
4.78%
-1.51
시간 외 거래:
29.60
-0.46
-1.53%
전일 마감가:
$31.57
열려 있는:
$31
하루 거래량:
1.91M
Relative Volume:
1.06
시가총액:
$1.81B
수익:
$362.27M
순이익/손실:
$-85.19M
주가수익비율:
-20.73
EPS:
-1.45
순현금흐름:
$-68.71M
1주 성능:
-10.46%
1개월 성능:
-3.25%
6개월 성능:
-23.39%
1년 성능:
-28.51%
1일 변동 폭
$29.71
$31.40
1주일 범위
$29.71
$34.08
52주 변동 폭
$24.07
$55.33
트위스트 바이오사이언스 Stock (TWST) Company Profile
명칭
Twist Bioscience Corp
전화
800-719-0671
주소
681 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA
TWST을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TWST
Twist Bioscience Corp
|
30.06 | 1.91B | 362.27M | -85.19M | -68.71M | -1.45 |
|
TMO
Thermo Fisher Scientific Inc
|
565.24 | 212.23B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
213.83 | 151.20B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
722.12 | 57.84B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
146.08 | 41.02B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
210.96 | 36.42B | 15.90B | 1.28B | 2.21B | 7.2842 |
트위스트 바이오사이언스 Stock (TWST) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-13 | 개시 | Wolfe Research | Outperform |
| 2024-06-04 | 개시 | Guggenheim | Buy |
| 2024-01-17 | 업그레이드 | Goldman | Neutral → Buy |
| 2023-09-27 | 개시 | Berenberg | Buy |
| 2023-01-05 | 개시 | Scotiabank | Sector Outperform |
| 2023-01-03 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2022-03-02 | 재개 | Cowen | Outperform |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-06-29 | 개시 | William Blair | Outperform |
| 2021-06-04 | 개시 | Goldman | Neutral |
| 2021-04-12 | 개시 | Piper Sandler | Overweight |
| 2021-02-05 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2021-01-04 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2020-10-20 | 개시 | SVB Leerink | Mkt Perform |
| 2019-05-31 | 개시 | Evercore ISI | Outperform |
| 2018-11-26 | 개시 | JP Morgan | Neutral |
모두보기
트위스트 바이오사이언스 주식(TWST)의 최신 뉴스
This Twist Bioscience Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Benzinga
Stephens & Co. Initiates Coverage on TWST with Overweight Rating - GuruFocus
Twist Bioscience to Present at 7th Annual Wolfe Research Healthcare Conference - Business Wire
Stephens initiates Twist Bioscience stock with Overweight rating, $41 target - Investing.com
Twist Bioscience Corporation (NASDAQ:TWST) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Live market analysis of Twist Bioscience CorporationPortfolio Value Report & Free Safe Entry Trade Signal Reports - newser.com
Will Twist Bioscience Corporation outperform the marketEarnings Overview Report & Technical Entry and Exit Tips - newser.com
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - Business Wire
Is Twist Bioscience Corporation (0ME) stock prepared for digital transitionJuly 2025 Update & AI Forecasted Entry/Exit Points - newser.com
What does recent volatility data suggest for Twist Bioscience CorporationWeekly Profit Recap & Daily Oversold Stock Bounce Ideas - newser.com
Combining machine learning predictions for Twist Bioscience CorporationWeekly Trend Summary & Safe Capital Investment Plans - newser.com
Long term hold vs stop loss in Twist Bioscience CorporationMarket Risk Analysis & Consistent Return Strategy Ideas - newser.com
Is Twist Bioscience Corporation stock ready for breakoutJuly 2025 Pullbacks & Safe Capital Growth Plans - newser.com
What insider trading reveals about Twist Bioscience Corporation stockInsider Selling & Weekly High Return Stock Opportunities - newser.com
Will Twist Bioscience Corporation bounce back from current support - newser.com
Is Twist Bioscience Corporation (0ME) stock trading at attractive multiples2025 Short Interest & Risk Adjusted Buy and Sell Alerts - newser.com
Jennison Associates LLC Has $22.75 Million Stock Position in Twist Bioscience Corporation $TWST - MarketBeat
How sustainable is Twist Bioscience Corporation stock dividend payoutJuly 2025 Macro Moves & Safe Entry Momentum Tips - newser.com
Is Twist Bioscience Corporation forming a reversal patternWeekly Trade Analysis & AI Enhanced Market Trend Forecasts - newser.com
[Form 4] Twist Bioscience Corp Insider Trading Activity - Stock Titan
TWST insider Form 4: 29,518 PSUs credited; holdings 128,228 - Stock Titan
TWST Form 4: 35,513 PSUs credited; 60% vest by Oct 1, 2026 - Stock Titan
TWST Form 4: CAO reports 5,633-share PSU award, vesting in 2026 - Stock Titan
Form 4: TWST CFO reports 25,000 shares; 60% vests by Oct 1, 2026 - Stock Titan
Will Twist Bioscience Corporation stock continue upward momentumJuly 2025 EndofMonth & Long-Term Safe Investment Ideas - newser.com
How Twist Bioscience Corporation stock compares to market leadersWeekly Profit Recap & AI Optimized Trade Strategies - newser.com
Will Twist Bioscience Corporation stock return to pre crisis levels - newser.com
Is Twist Bioscience Corporation stock undervalued vs historical averagesEntry Point & Safe Entry Momentum Tips - newser.com
Why Twist Bioscience Corporation (0ME) stock appeals to dividend investorsRate Hike & Daily Market Momentum Tracking - fcp.pa.gov.br
Top chart patterns to watch in Twist Bioscience Corporation2025 Stock Rankings & Consistent Profit Alerts - newser.com
Volatility clustering patterns for Twist Bioscience CorporationPortfolio Risk Report & Free Technical Pattern Based Buy Signals - newser.com
Is a relief rally coming for Twist Bioscience Corporation holdersDividend Hike & Safe Capital Growth Plans - newser.com
Is Twist Bioscience Corporation stock in correction or buying zoneJuly 2025 Earnings & Reliable Volume Spike Alerts - newser.com
Twist Bioscience Stock Soars 7.16%, Hits Intraday High of $34.18 - Markets Mojo
Will Twist Bioscience Corporation stock beat EPS estimatesMarket Activity Recap & Entry Point Confirmation Alerts - newser.com
Twist Bioscience COO Finn sells $69k in shares By Investing.com - Investing.com Canada
Twist Bioscience COO Finn sells $69k in shares - Investing.com
Twist Bioscience Exec Sells Shares to Cover Tax Obligations - TradingView
TWST Form 4: COO sold 2,240 shares at $30.875 for tax withholding - Stock Titan
Is Twist Bioscience Corporation building a consolidation baseWatch List & Fast Moving Stock Trade Plans - newser.com
트위스트 바이오사이언스 (TWST) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.45%
6.29%
자본화:
|
볼륨(24시간):